Published in Obesity and Diabetes Week, April 11th, 2005
The FSA approval provides a 4-year window in which the company can continue to sell Chromax while the European Food Safety Authority (EFSA) reviews the dossier. If approved by the EFSA, it will result in Chromax formal adoption as an approved source of trivalent chromium into EU legislation. Nutrition 21 will also request approval in other countries, including Austria, Germany and Ireland during the EFSA review process.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.